
NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Lipoprotein(a) Management Simplified: The National Lipid Association Lipid Simplified Series
This document aims to provide practical guidance on testing and management of Lp(a) for primary and secondary ASCVD risk management.
Top Line Results from the Phase 3 Lp(a)HORIZON Trial
On September 4, 2026, Novartis announced the topline results of its phase 3 Lp(a)HORIZON trial. Novartis shared that while pelacarsen lowered lipoprotein(a) [Lp(a)] levels, the…
Make Your Voice Heard: Support LDL-C Quality Measurement in the CMS CY 2027 Physician Fee Schedule
The Centers for Medicare & Medicaid Services (CMS) is accepting public comments on the Calendar Year (CY) 2027 Medicare Physician Fee Schedule Proposed Rule, and…
Update on Familial Hypercholesterolemia: An Expert Clinical Consensus from the National Lipid Association
This Expert Clinical Consensus provides redefined diagnostic criteria, updated ICD-10 codes, and guidance on genetic testing and cascade screening.
LDL Cholesterol Management Simplified in Adults—Lower for Longer is Better: Guidance from the National Lipid Association
The primary goals for LDL-C management are to achieve an acceptable level for the patient’s risk category and to maintain that over time.
Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care: A National Lipid Association Expert Clinical Review
Multidisciplinary care teams lead to improved lipid management and cardiometabolic health.
Managing Hypercholesterolemia in Adults Older Than 75 Years Without a History of Atherosclerotic Cardiovascular Disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society
Statins reduce ASCVD events in adults older than75 years without prior ASCVD.
Recognition and Management of Persistent Chylomicronemia: A Joint Expert Clinical Consensus by the National Lipid Association and the American Society for Preventive Cardiology
Patients with persistent chylomicronemia and alarm features have a very high risk of acute pancreatitis, similar to FCS.